Cargando…
Body Mass Index, Vitamin D, and Type 2 Diabetes: A Systematic Review and Meta-Analysis
The deficiency of vitamin D is prevalent all over the world. Studies have shown that vitamin D may play an important role in the development of obesity. The current study was conducted to quantitatively evaluate the association between serum 25-(OH) vitamin D levels and the risk of obesity in both d...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164132/ https://www.ncbi.nlm.nih.gov/pubmed/30154381 http://dx.doi.org/10.3390/nu10091182 |
_version_ | 1783359527409680384 |
---|---|
author | Rafiq, Shamaila Jeppesen, Per Bendix |
author_facet | Rafiq, Shamaila Jeppesen, Per Bendix |
author_sort | Rafiq, Shamaila |
collection | PubMed |
description | The deficiency of vitamin D is prevalent all over the world. Studies have shown that vitamin D may play an important role in the development of obesity. The current study was conducted to quantitatively evaluate the association between serum 25-(OH) vitamin D levels and the risk of obesity in both diabetic and non-diabetic subjects. A systematic review and meta-analysis of observational studies was carried out for that purpose. We searched the Medline, PubMed, and Embase databases throughout all of March 2018. A total of fifty five observational studies for both diabetic and non-diabetic subjects were finally included in the meta-analysis. The data were analyzed by comprehensive meta-analysis software version 3 and the random effects model was used to analyze the data. The meta-analysis showed an overall inverse relationship between serum vitamin D status and body mass index (BMI) in studies of both diabetic (r = −0.173, 95% = −0.241 to −0.103, p = 0.000) and non-diabetic (r = −0.152, 95% = −0.187 to −0.116, p = 0.000) subjects. The evidence of publication bias was not found in this meta-analysis. In conclusion, the deficiency of vitamin D is associated with an increased level of BMI in the studies of both diabetic and non-diabetic subjects. Reliable evidence from well-designed future randomized controlled trials is required to confirm the findings from observational studies and to find out the potential regulatory effects of vitamin D supplementation to lower BMI. |
format | Online Article Text |
id | pubmed-6164132 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-61641322018-10-10 Body Mass Index, Vitamin D, and Type 2 Diabetes: A Systematic Review and Meta-Analysis Rafiq, Shamaila Jeppesen, Per Bendix Nutrients Review The deficiency of vitamin D is prevalent all over the world. Studies have shown that vitamin D may play an important role in the development of obesity. The current study was conducted to quantitatively evaluate the association between serum 25-(OH) vitamin D levels and the risk of obesity in both diabetic and non-diabetic subjects. A systematic review and meta-analysis of observational studies was carried out for that purpose. We searched the Medline, PubMed, and Embase databases throughout all of March 2018. A total of fifty five observational studies for both diabetic and non-diabetic subjects were finally included in the meta-analysis. The data were analyzed by comprehensive meta-analysis software version 3 and the random effects model was used to analyze the data. The meta-analysis showed an overall inverse relationship between serum vitamin D status and body mass index (BMI) in studies of both diabetic (r = −0.173, 95% = −0.241 to −0.103, p = 0.000) and non-diabetic (r = −0.152, 95% = −0.187 to −0.116, p = 0.000) subjects. The evidence of publication bias was not found in this meta-analysis. In conclusion, the deficiency of vitamin D is associated with an increased level of BMI in the studies of both diabetic and non-diabetic subjects. Reliable evidence from well-designed future randomized controlled trials is required to confirm the findings from observational studies and to find out the potential regulatory effects of vitamin D supplementation to lower BMI. MDPI 2018-08-28 /pmc/articles/PMC6164132/ /pubmed/30154381 http://dx.doi.org/10.3390/nu10091182 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Rafiq, Shamaila Jeppesen, Per Bendix Body Mass Index, Vitamin D, and Type 2 Diabetes: A Systematic Review and Meta-Analysis |
title | Body Mass Index, Vitamin D, and Type 2 Diabetes: A Systematic Review and Meta-Analysis |
title_full | Body Mass Index, Vitamin D, and Type 2 Diabetes: A Systematic Review and Meta-Analysis |
title_fullStr | Body Mass Index, Vitamin D, and Type 2 Diabetes: A Systematic Review and Meta-Analysis |
title_full_unstemmed | Body Mass Index, Vitamin D, and Type 2 Diabetes: A Systematic Review and Meta-Analysis |
title_short | Body Mass Index, Vitamin D, and Type 2 Diabetes: A Systematic Review and Meta-Analysis |
title_sort | body mass index, vitamin d, and type 2 diabetes: a systematic review and meta-analysis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164132/ https://www.ncbi.nlm.nih.gov/pubmed/30154381 http://dx.doi.org/10.3390/nu10091182 |
work_keys_str_mv | AT rafiqshamaila bodymassindexvitamindandtype2diabetesasystematicreviewandmetaanalysis AT jeppesenperbendix bodymassindexvitamindandtype2diabetesasystematicreviewandmetaanalysis |